These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6118419)

  • 1. Amphetamine, p-hydroxyamphetamine and beta-phenethylamine in mouse brain and urine after (-)- and (+)-deprenyl administration.
    Philips SR
    J Pharm Pharmacol; 1981 Nov; 33(11):739-41. PubMed ID: 6118419
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of acute and chronic injections of d-amphetamine sulfate and substantia nigra lesions on the distribution of amphetamine and para-hydroxyamphetamine in the rat brain.
    Danielson TJ; Petrali EH; Wishart TB
    Life Sci; 1976 Oct; 19(8):1265-9. PubMed ID: 994725
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment.
    Karoum F; Chuang LW; Eisler T; Calne DB; Liebowitz MR; Quitkin FM; Klein DF; Wyatt RJ
    Neurology; 1982 May; 32(5):503-9. PubMed ID: 6803190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species variation with respect to the metabolism and excretion of d-amphetamine and d,l-N-hydroxyamphetamine succinate.
    Danielson TJ; Davis BA; Boulton AA
    Can J Physiol Pharmacol; 1977 Jun; 55(3):439-43. PubMed ID: 884602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine and 2-phenylethylamine in post-mortem Parkinsonian brain after (-)deprenyl administration.
    Reynolds GP; Riederer P; Sandler M; Jellinger K; Seemann D
    J Neural Transm; 1978; 43(3-4):271-7. PubMed ID: 745019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Phenylethylamine and amphetamine in human brain: effects of L-deprenyl in Parkinson's disease [proceedings].
    Reynolds GP; Riederer P; Sandler M
    Biochem Soc Trans; 1979 Feb; 7(1):143-5. PubMed ID: 437259
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative subcellular localization of para-hydroxylated derivatives of ephedrine and amphetamine in rat brain].
    El Guedri H; Rapin J; Jacquot C; Cohen Y
    C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(9):587-9. PubMed ID: 813909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple, small dose administration of (-)deprenyl enhances catecholaminergic activity and diminishes serotoninergic activity in the brain and these effects are unrelated to MAO-B inhibition.
    Knoll J; Miklya I
    Arch Int Pharmacodyn Ther; 1994; 328(1):1-15. PubMed ID: 7893186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of alpha-methyldopamine ("Catecholamphetamine") from p-hydroxyamphetamine by rat brain microsomes.
    Hoffman AR; Sastry BV; Axelrod J
    Pharmacology; 1979; 19(5):256-60. PubMed ID: 538080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-propargylbenzylamine, a major metabolite of pargyline, is a potent inhibitor of monoamine oxidase type B in rats in vivo: a comparison with deprenyl.
    Karoum F
    Br J Pharmacol; 1987 Feb; 90(2):335-45. PubMed ID: 3103805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phenethylamine derivatives on the release of biogenic amines from synaptosomes.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Biochem Soc Trans; 1976; 4(1):121-4. PubMed ID: 1001613
    [No Abstract]   [Full Text] [Related]  

  • 13. Stereotyped behavior and hyperthermia in dogs: correlation with the levels of amphetamine and p-hydroxyamphetamine in plasma and CSF.
    Bareggi SR; Gomeni R; Becker RE
    Psychopharmacology (Berl); 1978 Jun; 58(1):89-94. PubMed ID: 97724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of (-) deprenyl on monoamine turnover rate in rat brain.
    Zsilla G; Knoll J
    Adv Biochem Psychopharmacol; 1982; 31():211-7. PubMed ID: 6805258
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution and localization of p-hydroxy-d-amphetamine in rat brain.
    Jori A; Caccia S; Guiso G; Garattini S
    Eur J Pharmacol; 1978 Dec; 52(3-4):361-5. PubMed ID: 729645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog.
    Milgram NW; Ivy GO; Head E; Murphy MP; Wu PH; Ruehl WW; Yu PH; Durden DA; Davis BA; Paterson IA
    Neurochem Res; 1993 Dec; 18(12):1211-9. PubMed ID: 8272186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary excretion of amphetamine and 4'-hydroxyamphetamine by Sprague Dawley and dark Agouti rats.
    Law MY; Moody DE
    Life Sci; 1994; 54(15):1073-9. PubMed ID: 8152328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood-brain barrier. II. Kinetics of distribution of 3H-parahydroxyamphetamine in brain structures after intravenous administration in the rat].
    Lindenbaum A; Marcher K; Wepierre J; Cohen Y
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):168-76. PubMed ID: 1164084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective storage of p-hydroxy-d-amphetamine in the dopaminergic nerve terminals.
    Jori A; Caccia S; Guiso A; Ballabio M; Garattini S
    Biochem Pharmacol; 1979 Apr; 28(7):1205-7. PubMed ID: 444278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.